About Hôpital Saint-Louis - Service d'hématologie AJA
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Groupe Francophone des Myelodysplasies
2
Clinical Trials at Hôpital Saint-Louis - Service d'hématologie AJA
During the past decade, Hôpital Saint-Louis - Service d'hématologie AJA conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients
2015-02-10
2018-08-01
Completed
23
A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
2014-08-07
2021-04-01
Completed
30
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Saint-Louis - Service d'hématologie AJA"
#1 collaborator was "Novartis" with 2 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hôpital Saint-Louis - Service d'hématologie AJA
According to Clinical.Site data, the most researched conditions in "Hôpital Saint-Louis - Service d'hématologie AJA" are
"CMML" (1 trials), "MDS" (1 trials) and "Thrombocytopenia" (1 trials). Many other conditions were trialed in "Hôpital Saint-Louis - Service d'hématologie AJA" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Saint-Louis - Service d'hématologie AJA
Most popular intervention types in "Hôpital Saint-Louis - Service d'hématologie AJA" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine and LDE255" (1 trials) and "eltrombopag" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Saint-Louis - Service d'hématologie AJA
The vast majority of trials in "Hôpital Saint-Louis - Service d'hématologie AJA" are
2 trials for "All" genders.
Clinical Trials Status at Hôpital Saint-Louis - Service d'hématologie AJA
Currently, there are NaN active trials in "Hôpital Saint-Louis - Service d'hématologie AJA".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hôpital Saint-Louis - Service d'hématologie AJA,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Saint-Louis - Service d'hématologie AJA, 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".